MedTrace Logo

Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

NCT00004341 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES: I. Identify the molecular defects responsible for primary immunodeficiency disorders.

II. Explore the mutations within each syndrome to better understand the genetics of these disorders.

III. Study the function of the Wiskott-Aldrich syndrome proteins (WASP). IV. Design methods to identify carriers and for prenatal diagnosis. V. Explore new avenues for therapy.

Conditions

  • X-Linked Agammaglobulinemia
  • X-Linked Hyper IgM Syndrome
  • Wiskott-Aldrich Syndrome
  • Leukocyte Adhesion Deficiency Syndrome

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    lead NIH

Principal Investigators

  • Hans D. Ochs · University of Washington

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004341 on ClinicalTrials.gov